CYANOCOBALAMIN Side Effects

6925103-9 | Tremor
on Jul 27, 2010 Female patient from UNITED STATES , 74 years of age, was treated with Cyanocobalamin (View Usage). Patient experienced the following unwanted or unexpected effects: tremor. Cyanocobalamin dosage: .

6836583-1 | Cellulitis, Secretion Discharge
Patient was taking Cyanocobalamin (View Usage). Patient had the following side effects: cellulitis (What is cellulitis?), secretion discharge on Jun 23, 2010 from UNITED STATES Additional patient health information: Female patient , 52 years of age, was diagnosed with anaemia, vitamin b12 deficiency and. Cyanocobalamin dosage: 1000 Mcg Weekly Subcutaneous.

6583968-7 | Myocardial Infarction
Adverse event was reported on Feb 13, 2010 by a Male patient taking Cyanocobalamin (View Usage) (Dosage: 30ml 0multi Dose Vial- Im) was diagnosed with asthenia and. Location: UNITED STATES , 89 years of age, weighting 168.0 lb, After Cyanocobalamin was administered, patient had the following side effects: myocardial infarction.

6426814-4 | Hypersensitivity, Pruritus, Rash, Respiratory Depression, Urticaria
on Nov 03, 2009 Male patient from UNITED STATES , 57 years of age, weighting 234.8 lb, was treated with Cyanocobalamin (View Usage). Patient experienced the following unwanted or unexpected effects: hypersensitivity, pruritus, rash (What is rash?), respiratory depression, urticaria. Cyanocobalamin dosage: Other Po.


6218896-X |
on Jun 03, 2009 Female patient from JAPAN , weighting 101.4 lb, was diagnosed with hypertension and was treated with Cyanocobalamin (View Usage). . Cyanocobalamin dosage: . During the same period patient was treated with SEDIEL (10 Mg) (View Sediel Review and Sediel Label ), NAUZELIN (10 Mg) (View Nauzelin Review and Nauzelin Label ), PAXIL (10 Mg) (View Paxil Review and Paxil Label ), MYSLEE (10 Mg) (View Myslee Review and Myslee Label ), URSO 250 (View Urso 250 Review and Urso 250 Label ), DOGMATYL (View Dogmatyl Review and Dogmatyl Label ), SELECTOL (View Selectol Review and Selectol Label ), TANATRIL (5 Mg) (View Tanatril Review and Tanatril Label ).

6167200-4 | Sepsis
Patient was taking Cyanocobalamin (View Usage). After Cyanocobalamin was administered, patient had the following side effects: sepsis (What is sepsis?) on Apr 10, 2009 from UNITED STATES Additional patient health information: Male patient , 75 years of age, . Cyanocobalamin dosage: 1000 Ug/ml;. During the same period patient was treated with ALBUTEROL (View Albuterol Review and Albuterol Label ), AZITHROMYCIN (View Azithromycin Review and Azithromycin Label ), EPOETIN (View Epoetin Review and Epoetin Label ), SIMVASTATIN (View Simvastatin Review and Simvastatin Label ), WARFARIN (View Warfarin Review and Warfarin Label ), DIGOXIN (View Digoxin Review and Digoxin Label ), FUROSEMIDE (View Furosemide Review and Furosemide Label ), POTASSIUM CHLORIDE (View Potassium Chloride Review and Potassium Chloride Label ).

6161453-4 | Blister, Rash, Scar, Skin Disorder
Adverse event was reported on Apr 17, 2009 by a Male patient taking Cyanocobalamin (View Usage) (Dosage: /ml Every 3 Weeks (duration: Since 1981)) was diagnosed with crohn's disease (What is crohn's disease?), intestinal resection and. Location: UNITED STATES , weighting 150.0 lb, Patient experienced the following unwanted or unexpected effects: blister, rash (What is rash?), scar (What is scar?), skin disorder.

6061289-9 | Anaemia Of Chronic Disease, Arthralgia, Asthenia, Back Disorder, Back Pain, Basal Cell Carcinoma, Bone Pain, Bronchitis
on Jan 21, 2009 Female patient from UNITED STATES , 77 years of age, weighting 134.5 lb, was diagnosed with pernicious anaemia, fracture (What is fracture?), osteoporosis (What is osteoporosis?) and was treated with Cyanocobalamin (View Usage). Patient had the following side effects: anaemia of chronic disease, arthralgia, asthenia, back disorder, back pain (What is back pain?), basal cell carcinoma, bone pain, bronchitis (What is bronchitis?). Cyanocobalamin dosage: . During the same period patient was treated with SYNTHROID (View Synthroid Review and Synthroid Label ), TUMS (View Tums Review and Tums Label ), EVISTA (View Evista Review and Evista Label ), FOSAMAX (View Fosamax Review and Fosamax Label ), MECLIZINE (View Meclizine Review and Meclizine Label ). Patient was hospitalized and became disabled.

6023259-6 |
on Dec 25, 2008 Female patient from JAPAN , weighting 101.4 lb, was diagnosed with hypertension and was treated with Cyanocobalamin (View Usage). . Cyanocobalamin dosage: . During the same period patient was treated with SEDIEL (10 Mg) (View Sediel Review and Sediel Label ), NAUZELIN (10 Mg) (View Nauzelin Review and Nauzelin Label ), PAXIL (10 Mg) (View Paxil Review and Paxil Label ), MYSLEE (10 Mg) (View Myslee Review and Myslee Label ), URSO 250 (View Urso 250 Review and Urso 250 Label ), DOGMATYL (View Dogmatyl Review and Dogmatyl Label ), SELECTOL (View Selectol Review and Selectol Label ), TANATRIL (5 Mg) (View Tanatril Review and Tanatril Label ).

5993037-2 | Conjunctival Hyperaemia, Periorbital Oedema, Pruritus, Vasodilatation
Patient was taking Cyanocobalamin (View Usage). Patient experienced the following unwanted or unexpected effects: conjunctival hyperaemia, periorbital oedema, pruritus, vasodilatation on Dec 10, 2008 from UNITED STATES Additional patient health information: Male patient , 77 years of age, weighting 186.0 lb, was diagnosed with vitamin b12 deficiency and. Cyanocobalamin dosage: .

5982056-8 | Headache
Adverse event was reported on Nov 13, 2008 by a Female patient taking Cyanocobalamin (View Usage) (Dosage: 2 Ml Monthly Intramuscular) . Location: UNITED STATES , 22 years of age, weighting 190.0 lb, Patient had the following side effects: headache (What is headache?). Patient was hospitalized.

5867287-X | Anaemia, Disease Progression, Hypoxia, Lung Infiltration, Nephrolithiasis, Pneumonia, Respiratory Arrest, Unresponsive To Stimuli
on Aug 29, 2008 Male patient from UNITED STATES , weighting 159.3 lb, was treated with Cyanocobalamin (View Usage). After Cyanocobalamin was administered, patient had the following side effects: anaemia, disease progression, hypoxia, lung infiltration, nephrolithiasis, pneumonia (What is pneumonia?), respiratory arrest, unresponsive to stimuli. Cyanocobalamin dosage: 1000 Mcg. During the same period patient was treated with DEXAMETHASONE TAB (24 Mg) (View Dexamethasone Tab Review and Dexamethasone Tab Label ), FOLIC ACID (5600 Mcg) (View Folic Acid Review and Folic Acid Label ), PEMETREXED (930 Mg) (View Pemetrexed Review and Pemetrexed Label ).

5832446-9 | Liver Disorder
on Jul 23, 2008 Female patient from JAPAN , 61 years of age, was treated with Cyanocobalamin (View Usage). Patient experienced the following unwanted or unexpected effects: liver disorder. Cyanocobalamin dosage: 500 Mcg. During the same period patient was treated with ADETPHOS (100 Mg) (View Adetphos Review and Adetphos Label ), MYSLEE (10 Mg) (View Myslee Review and Myslee Label ), SAIKO KA RYUKOTSU BOREI TO (CHINESE HERBAL MEDICINE) (Unk) (View Saiko-ka-ryukotsu-borei-to (chinese Herbal Medicine) Review and Saiko-ka-ryukotsu-borei-to (chinese Herbal Medicine) Label ).

5815152-6 | Liver Disorder
Patient was taking Cyanocobalamin (View Usage). Patient had the following side effects: liver disorder on Jul 08, 2008 from JAPAN Additional patient health information: Female patient , 61 years of age, . Cyanocobalamin dosage: 500 Mcg. During the same period patient was treated with ADETPHOS (100 Mg) (View Adetphos Review and Adetphos Label ), MYSLEE (10 Mg) (View Myslee Review and Myslee Label ).

5788084-X | Liver Disorder
Adverse event was reported on Jun 17, 2008 by a Female patient taking Cyanocobalamin (View Usage) (Dosage: 500 Mcg) . Location: JAPAN , 61 years of age, After Cyanocobalamin was administered, patient had the following side effects: liver disorder. During the same period patient was treated with ADETPHOS (100 Mg) (View Adetphos Review and Adetphos Label ), MYSLEE (10 Mg) (View Myslee Review and Myslee Label ).

5742026-1 | Arthralgia, Basal Cell Carcinoma, Bone Pain, Bronchitis, Cardiac Tamponade, Catheter Related Complication, Chest Discomfort, Chest Pain
on May 07, 2008 Female patient from UNITED STATES , 77 years of age, weighting 134.5 lb, was diagnosed with pernicious anaemia, fracture (What is fracture?), osteoporosis (What is osteoporosis?) and was treated with Cyanocobalamin (View Usage). Patient experienced the following unwanted or unexpected effects: arthralgia, basal cell carcinoma, bone pain, bronchitis (What is bronchitis?), cardiac tamponade, catheter related complication, chest discomfort, chest pain (What is chest pain?). Cyanocobalamin dosage: . During the same period patient was treated with SYNTHROID (View Synthroid Review and Synthroid Label ), TUMS (View Tums Review and Tums Label ), EVISTA (View Evista Review and Evista Label ), FOSAMAX (View Fosamax Review and Fosamax Label ), MECLIZINE (View Meclizine Review and Meclizine Label ). Patient was hospitalized and became disabled.

5717339-X | Aortic Dissection
on Apr 24, 2008 Female patient from UNITED STATES , 85 years of age, weighting 125.0 lb, was diagnosed with red blood cell count and was treated with Cyanocobalamin (View Usage). Patient had the following side effects: aortic dissection. Cyanocobalamin dosage: 1ml Once Im.

5646599-9 | Adhesion, Alanine Aminotransferase Increased, Anorexia, Aspartate Aminotransferase Increased, Blood Alkaline Phosphatase Increased, Blood Creatine Phosphokinase Increased, Blood Lactate Dehydrogenase Increased, Body Temperature Decreased, Erythema
Patient was taking Cyanocobalamin (View Usage). After Cyanocobalamin was administered, patient had the following side effects: adhesion (What is adhesion?), alanine aminotransferase increased, anorexia, aspartate aminotransferase increased, blood alkaline phosphatase increased, blood creatine phosphokinase increased, blood lactate dehydrogenase increased, body temperature decreased, erythema on Feb 21, 2008 from JAPAN Additional patient health information: Male patient , 58 years of age, weighting 141.1 lb, was diagnosed with tremor and. Cyanocobalamin dosage: . During the same period patient was treated with TEGRETOL (200 Mg) (View Tegretol Review and Tegretol Label ), HISHIPHAGEN C (View Hishiphagen-c Review and Hishiphagen-c Label ), GLYCYRON (View Glycyron Review and Glycyron Label ). Patient was hospitalized.

5612715-8 | Adhesion, Alanine Aminotransferase Increased, Anorexia, Aspartate Aminotransferase Increased, Blood Alkaline Phosphatase Increased, Blood Creatine Phosphokinase Increased, Blood Lactate Dehydrogenase Increased, Body Temperature Decreased, Erythema
Adverse event was reported on Jan 29, 2008 by a Male patient taking Cyanocobalamin (View Usage) (Dosage: ) was diagnosed with tremor and. Location: JAPAN , 58 years of age, weighting 141.1 lb, Patient experienced the following unwanted or unexpected effects: adhesion (What is adhesion?), alanine aminotransferase increased, anorexia, aspartate aminotransferase increased, blood alkaline phosphatase increased, blood creatine phosphokinase increased, blood lactate dehydrogenase increased, body temperature decreased, erythema. During the same period patient was treated with TEGRETOL (200 Mg) (View Tegretol Review and Tegretol Label ), HISHIPHAGEN C (View Hishiphagen-c Review and Hishiphagen-c Label ), GLYCYRON (View Glycyron Review and Glycyron Label ). Patient was hospitalized.

5388849-2 | Therapeutic Response Decreased
on Jul 02, 2007 Female patient from UNITED STATES , 64 years of age, weighting 243.0 lb, was diagnosed with pernicious anaemia and was treated with Cyanocobalamin (View Usage). Patient had the following side effects: therapeutic response decreased. Cyanocobalamin dosage: Intramuscular.

5039894-8 | Acute Myocardial Infarction, Asthenia, Blood Creatine Phosphokinase Increased, Blood Creatine Phosphokinase Mb, Chest Pain, Dyspnoea, Hypertension, Red Blood Cell Sedimentation Rate Increased, Troponin T Increased
on Feb 17, 2006 Male patient from GERMANY , 37 years of age, weighting 198.4 lb, was diagnosed with gastrointestinal stromal tumour and was treated with Cyanocobalamin (View Usage). After Cyanocobalamin was administered, patient had the following side effects: acute myocardial infarction, asthenia, blood creatine phosphokinase increased, blood creatine phosphokinase mb, chest pain (What is chest pain?), dyspnoea, hypertension, red blood cell sedimentation rate increased, troponin t increased. Cyanocobalamin dosage: 1 Df, Qmo. During the same period patient was treated with GLEEVEC (400 Mg, Qd) (View Gleevec Review and Gleevec Label ). Patient was hospitalized.

4943436-2 | Pernicious Anaemia, Psychotic Disorder, Vitamin B12 Decreased
Patient was taking Cyanocobalamin (View Usage). Patient experienced the following unwanted or unexpected effects: pernicious anaemia, psychotic disorder (What is psychotic disorder?), vitamin b12 decreased on Mar 13, 2006 from UNITED STATES Additional patient health information: Female patient , 51 years of age, weighting 168.0 lb, was diagnosed with pernicious anaemia, psychotic disorder (What is psychotic disorder?) and. Cyanocobalamin dosage: 1000 Mg Given Im On Each Of Listed Dates.

4897556-1 | Rash Maculo-papular
Adverse event was reported on Jan 30, 2006 by a Male patient taking Cyanocobalamin (View Usage) (Dosage: 1000 Mcg Im X 1) was diagnosed with vitamin b12 deficiency and. Location: UNITED STATES , 53 years of age, weighting 271.2 lb, Patient had the following side effects: rash maculo-papular.

4843854-7 | Angina Pectoris, Back Pain, Difficulty In Walking, Mass, Myocardial Infarction
on Nov 15, 2005 Female patient from CANADA , 75 years of age, was treated with Cyanocobalamin (View Usage). After Cyanocobalamin was administered, patient had the following side effects: angina pectoris, back pain (What is back pain?), difficulty in walking, mass, myocardial infarction. Cyanocobalamin dosage: 1000 Mcg, Once A Month, Intramuscular. During the same period patient was treated with SYNTHROID (View Synthroid Review and Synthroid Label ), ALTACE (View Altace Review and Altace Label ).